… The EUCAST susceptible breakpoint for meropenem/vaborbactam … meropenem component
and the inhibitory activity of vaborbactam, compared with the standard dose of meropenem …

… infections caused by CR-GNB in 406 patients, 207 of whom had VAP [18]. … compare the
efficacy and safety of empirical treatment with intravenous colistin versus meropenem in patients …

… Acetaminophen was chosen as the internal standard due to structural and behavioral
similarities to meropenem. Initially, 950 μL of serum was added to 50 μL of acetaminophen (800 μg/…

… compared with colistin for the treatment of patients with BSI and hospital-acquired/ventilator-associated
bacterial pneumonia … Combination therapy with either tigecycline or meropenem, …

… (with 1,051 patients) of nosocomial pneumonia were compared between intermittent infusion
… variability of penetration in 39 VAP patients treated with meropenem 2 g IV infusion over 3 …

… and the pharmacokinetic parameter of not critically ill patients. We compared the efficacy
of high versus standard dose of meropenem in ventilator-associated pneumonia (VAP). …

… differences in the protein binding of meropenem in humans and rabbits. A 24-hour delay in
initial treatment was used for all patients… in patients with ventilator-associated pneumonia. Am …

… to increase meropenem exposure in ELF compared with … pneumonia in critically ill patients
(29). Considering our simulation results and this ELF penetration issue, meropenem should …

… 0.3 to 10.3% when identical scenarios were compared based on MIC distributions for the
non-… -pseudomonal-beta-lactams such as meropenem will be evaluated as comparator agents. …

… After combined with sulbactam or meropenem, the MIC 50 of levofloxacin was 1/2 of …
compared to that in single usage. FIC results in Table 5 suggested that sulbactam or meropenem …